retatrutide triple agonist obesity trial ๐จ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type 2 diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ Retatrutide is a triple-agonist (GLP-1
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Sep 27 - Oct 2




















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120470-2b143445f1924b8a9050fb3a639779df.jpg)






